Drug-Drug Interactions of Cannabidiol with Standard-of-Care Chemotherapeutics.

Humans Cannabidiol / pharmacology Cannabinoids / therapeutic use Cannabis Drug Interactions Neoplasms / drug therapy Antineoplastic Agents / pharmacology
cancer cannabidiol chemotherapy drug–drug interaction

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
02 Feb 2023
Historique:
received: 03 01 2023
revised: 24 01 2023
accepted: 30 01 2023
entrez: 11 2 2023
pubmed: 12 2 2023
medline: 15 2 2023
Statut: epublish

Résumé

Cannabidiol (CBD) is an easily accessible and affordable Marijuana (

Identifiants

DOI: 10.3390/ijms24032885 PMID: 36769206 PMC: PMC9917508
pubmed: 36769206
pii: ijms24032885
doi: 10.3390/ijms24032885
pmc: PMC9917508
pii:
doi:

Substances chimiques

Cannabidiol 19GBJ60SN5
Cannabinoids 0
Antineoplastic Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : ENOCH
ID : CZ.02.1.01/0.0/0.0/16_019/0000868
Organisme : Czech Science Foundation
ID : 20-28685S
Organisme : Internal grant of the University of Palacky
ID : IGA_LF_2022_038
Organisme : Danish National Research Foundation
ID : project CARD, DNRF 125
Organisme : European Union - Next Generation EU, National Institute for Cancer Research
ID : Programme EXCELES, ID Project No. LX22NPO5102

Références

Curr Med Chem. 2009;16(25):3267-85
pubmed: 19548866
Pharmacol Ther. 2017 Jul;175:133-150
pubmed: 28232276
Nat Cell Biol. 2012 Feb 02;14(2):117-23
pubmed: 22298039
BMC Biol. 2014 Nov 11;12:94
pubmed: 25385277
Curr Oncol. 2020 Apr;27(2):e199-e205
pubmed: 32489269
Cancers (Basel). 2019 Jun 05;11(6):
pubmed: 31195721
Oncogene. 2018 Dec;37(49):6368-6382
pubmed: 30061636
Lancet Neurol. 2010 Aug;9(8):807-19
pubmed: 20650402
Nat Rev Clin Oncol. 2017 Jul;14(7):417-433
pubmed: 28117417
Br J Pharmacol. 2021 Aug;178(15):3067-3078
pubmed: 33822373
Met Ions Life Sci. 2018 Feb 5;18:
pubmed: 29394020
Int J Pharm. 2020 Jan 25;574:118916
pubmed: 31811927
Ann Oncol. 1998 Jan;9(1):13-21
pubmed: 9541678
Eur J Med Chem. 2019 Jun 1;171:129-168
pubmed: 30917303
Toxicol Appl Pharmacol. 2008 Feb 1;226(3):260-70
pubmed: 17950393
Eur J Pharmacol. 2008 Sep 4;591(1-3):128-31
pubmed: 18619955
Cancer Drug Resist. 2021;4:17-43
pubmed: 34337348
Molecules. 2013 Oct 14;18(10):12663-74
pubmed: 24129275
Int J Cancer. 2013 Mar 15;132(6):1260-71
pubmed: 23180629
Anesth Analg. 2011 Oct;113(4):947-50
pubmed: 21737705
J Clin Med. 2019 Jul 08;8(7):
pubmed: 31288397
Br J Clin Pharmacol. 2015 Aug;80(2):253-66
pubmed: 25677219
Cell Death Dis. 2022 Mar 4;13(3):203
pubmed: 35246527
Autophagy. 2021 Nov;17(11):3592-3606
pubmed: 33629929
Anal Biochem. 2020 Mar 15;593:113530
pubmed: 31794703
Oral Dis. 2020 Oct;26(7):1483-1493
pubmed: 32400905
Cochrane Database Syst Rev. 2016 Apr 20;4:CD010816
pubmed: 27096326
Br J Pharmacol. 2014 Feb;171(3):636-45
pubmed: 24117398
Psychopharmacology (Berl). 2004 Jul;174(2):254-9
pubmed: 14740147
Cell Chem Biol. 2017 Sep 21;24(9):1161-1180
pubmed: 28938091
Lancet Oncol. 2016 Nov;17(11):1521-1532
pubmed: 27686946
J Clin Oncol. 1995 Oct;13(10):2643-55
pubmed: 7595719
Front Pharmacol. 2019 Oct 15;10:1198
pubmed: 31680972
AAPS J. 2005 May 11;7(1):E118-33
pubmed: 16146333
Ann Surg. 1931 Jan;93(1):190-9
pubmed: 17866462
Br J Pharmacol. 2007 Nov;152(5):815-24
pubmed: 17906686
Neurochem Res. 2005 Aug;30(8):1037-43
pubmed: 16258853
Mol Med. 2015 Jan 06;21:38-45
pubmed: 25569804
J Pharmacol Exp Ther. 2009 Mar;328(3):708-14
pubmed: 19074681
Br J Pharmacol. 2007 Dec;152(7):1092-101
pubmed: 17876302
Int J Mol Sci. 2021 Sep 18;22(18):
pubmed: 34576262
Int J Cancer. 2014 Jun 1;134(11):2534-46
pubmed: 24293211
Br J Pharmacol. 2012 Apr;165(8):2620-34
pubmed: 21827451
Biochem Biophys Res Commun. 2007 Nov 3;362(4):928-34
pubmed: 17765871
Lancet. 2018 Mar 17;391(10125):1085-1096
pubmed: 29395273
J Pharmacol Exp Ther. 2017 Jan;360(1):215-224
pubmed: 27821713
Br J Pharmacol. 2017 Sep;174(17):2832-2841
pubmed: 28548225
Nature. 2017 Dec 14;552(7684):194-199
pubmed: 29211715
Future Oncol. 2019 Mar;15(9):1035-1049
pubmed: 30720344
Proc Natl Acad Sci U S A. 2006 May 16;103(20):7895-900
pubmed: 16672367
Crit Rev Oncol Hematol. 2014 Jan;89(1):43-61
pubmed: 23972663
Environ Toxicol Pharmacol. 2013 Sep;36(2):347-357
pubmed: 23721741
Dalton Trans. 2018 May 15;47(19):6645-6653
pubmed: 29632935
Prog Chem Org Nat Prod. 2017;103:1-36
pubmed: 28120229
Biochem Pharmacol. 2018 Nov;157:266-274
pubmed: 30195736
Crit Rev Oncol Hematol. 2016 Jun;102:37-46
pubmed: 27105947
Clin Pharmacokinet. 1988 Jul;15(1):15-31
pubmed: 3042244
N Engl J Med. 2018 May 17;378(20):1888-1897
pubmed: 29768152
N Engl J Med. 2017 Aug 17;377(7):699-700
pubmed: 28813226
Biochem Pharmacol. 2006 Apr 14;71(8):1146-54
pubmed: 16458258
Br J Pharmacol. 2007 Mar;150(5):613-23
pubmed: 17245363
J Mol Neurosci. 2019 Aug;68(4):603-619
pubmed: 31077084
Drug Resist Updat. 2020 Sep;52:100691
pubmed: 32615524
Nat Rev Drug Discov. 2010 Oct;9(10):790-803
pubmed: 20885410
Future Oncol. 2005 Feb;1(1):7-17
pubmed: 16555971
Mol Oncol. 2022 Apr;16(7):1541-1554
pubmed: 34632694
Invest New Drugs. 1989 Jul;7(2-3):255-60
pubmed: 2793383
Cancer Manag Res. 2010 Nov 19;2:293-301
pubmed: 21301589
Dig Dis Sci. 2017 Jun;62(6):1615-1620
pubmed: 28349233
Br J Pharmacol. 2011 Aug;163(7):1411-22
pubmed: 21175589
Pharmacol Rev. 2004 Jun;56(2):185-229
pubmed: 15169927
Nat Rev Cancer. 2012 Jan 12;12(2):104-20
pubmed: 22237395
Curr Oncol Rep. 2003 Mar;5(2):114-25
pubmed: 12583828
Exp Biol Med (Maywood). 2019 Jul;244(10):850-854
pubmed: 31161774
Sci Rep. 2019 Aug 23;9(1):12301
pubmed: 31444479
J Neurosci. 2008 Jun 11;28(24):6231-8
pubmed: 18550765
J Proteomics. 2017 Jun 6;162:73-85
pubmed: 28478306
Int J Pharm. 2021 Sep 25;607:120943
pubmed: 34324983
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751388
J Am Chem Soc. 1971 May 5;93(9):2325-7
pubmed: 5553076
Expert Opin Drug Deliv. 2019 Mar;16(3):301-312
pubmed: 30773947
Cancer Treat Rev. 1982 Dec;9(4):313-30
pubmed: 6762924
Trends Cell Biol. 2018 Oct;28(10):776-792
pubmed: 29871823
Nat Rev Cancer. 2006 Jul;6(7):546-58
pubmed: 16794637
J Nat Prod. 2016 Feb 26;79(2):324-31
pubmed: 26836472
Cancer Biol Ther. 2019;20(8):1083-1090
pubmed: 31068075
J Psychopharmacol. 2011 Jan;25(1):121-30
pubmed: 20829306
PLoS One. 2021 Aug 5;16(8):e0255591
pubmed: 34352013
Methods Mol Biol. 2021;2174:143-170
pubmed: 32813249
Curr Neurol Neurosci Rep. 2016 Feb;16(2):13
pubmed: 26750128
Cancers (Basel). 2020 Nov 27;12(12):
pubmed: 33260923
N Engl J Med. 1948 Jun 3;238(23):787-93
pubmed: 18860765
Neurooncol Pract. 2017 Sep;4(3):151-160
pubmed: 31385997
BMC Res Notes. 2020 Aug 20;13(1):389
pubmed: 32819436
Transl Oncol. 2019 Mar;12(3):513-522
pubmed: 30597288
Front Oncol. 2019 Jan 18;8:643
pubmed: 30713832
Expert Opin Drug Saf. 2007 Sep;6(5):609-21
pubmed: 17877447
Oncogene. 2011 Jan 13;30(2):142-52
pubmed: 20838378
Eur J Pharmacol. 2009 Jun 10;612(1-3):61-8
pubmed: 19285060
Vet Comp Oncol. 2021 Jun;19(2):253-265
pubmed: 33247539
DNA Cell Biol. 2013 May;32(5):228-35
pubmed: 23590199
Mol Cancer Ther. 2002 Jan;1(3):227-35
pubmed: 12467217
Oral Oncol. 2013 Jun;49(6):615-9
pubmed: 23485743
Drug Deliv Transl Res. 2022 Nov;12(11):2762-2777
pubmed: 35217991
Int J Cancer. 2015 Oct 15;137(8):1855-69
pubmed: 25903924
Oncotarget. 2016 May 27;9(71):33459-33470
pubmed: 30323891
J Clin Med Res. 2020 Mar;12(3):129-141
pubmed: 32231748
Cancers (Basel). 2020 Sep 27;12(10):
pubmed: 32992648
Neurotox Res. 2021 Dec;39(6):1782-1799
pubmed: 34792764
Carcinogenesis. 2013 Jan;34(1):48-57
pubmed: 23079154
Proc Natl Acad Sci U S A. 2002 Nov 26;99(24):15387-92
pubmed: 12426403
Cancer. 2017 Nov 15;123(22):4488-4497
pubmed: 28944449
Eur J Pharm Biopharm. 2020 Sep;154:246-258
pubmed: 32682943
Br J Pharmacol. 2013 Jan;168(1):79-102
pubmed: 22594963
Br J Pharmacol. 2013 Mar;168(6):1456-70
pubmed: 23121618
AAPS J. 2018 Aug 27;20(6):94
pubmed: 30151644
J Psychopharmacol. 2014 Nov;28(11):1088-98
pubmed: 25237116
Bioorg Chem. 2019 Jul;88:102925
pubmed: 31003078
Br J Pharmacol. 2001 Oct;134(4):845-52
pubmed: 11606325
Transl Psychiatry. 2012 Mar 20;2:e94
pubmed: 22832859
Epilepsia. 2016 Oct;57(10):1617-1624
pubmed: 27696387
Int J Mol Sci. 2020 May 14;21(10):
pubmed: 32423175
Cancer. 2022 Jan 01;128(1):160-168
pubmed: 34636036
J Pharmacol Exp Ther. 2006 May;317(2):850-7
pubmed: 16439618
Anticancer Res. 2019 Oct;39(10):5797-5801
pubmed: 31570484

Auteurs

Tereza Buchtova (T)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77 147 Olomouc, Czech Republic.

David Lukac (D)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77 147 Olomouc, Czech Republic.

Zdenek Skrott (Z)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77 147 Olomouc, Czech Republic.
ORCID: 0000-0001-6004-3609

Katarina Chroma (K)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77 147 Olomouc, Czech Republic.
ORCID: 0000-0003-0141-0469

Jiri Bartek (J)

Danish Cancer Society Research Center, DK-2100 Copenhagen, Denmark.
Department of Medical Biochemistry and Biophysics, Science for Life Laboratory, Division of Genome Biology, Karolinska Institute, 171 77 Stockholm, Sweden.

Martin Mistrik (M)

Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University, 77 147 Olomouc, Czech Republic.
ORCID: 0000-0002-2321-0348

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Terpènes › Cannabinoïdes › Cannabidiol › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Composés chimiques organiques › Hydrocarbures › Terpènes › Cannabinoïdes › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Eucaryotes › Viridiplantae › Streptophyta › Embryophyta › Tracheobionta › Magnoliopsida › Rosanae › Rosales › Cannabaceae › Cannabis › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Interactions médicamenteuses › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Tumeurs › Drug-Drug Interactions of Cannabidiol with...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Antinéoplasiques › Drug-Drug Interactions of Cannabidiol with...